CTA highlights the best articles from the month of July 2018
Immuno-Oncology and Combination Trials: New Aspirations, Old Frustrations
Ramani A. Aiyer, Shasta BioVentures, explores the immuno-oncology landscape, shining a spotlight on the promise immunotherapy holds for the future
The Impact of Gene and Cell Therapy on the Supply Chain
Chad Presher & Meridith Hyres, Biogen, explore how industry supply chains are preparing for Gene and Cell Therapy treatments
The Arrival of Gene Therapy and Personalized Medicine
Keleni Micheal Tukia, Bristol-Myers Squibb, explores how advancements made in gene therapy is key in the ongoing fight against cancer
Scientific Breakthroughs for Treating CINV – Helping Patients Cope with Cancer Treatments
Michael Sydes, George Clinical, discusses the scientific breakthroughs for treating Chemotherapy Induced Nausea and Vomiting in cancer patients
Expert Insights: Amgen vs Sandoz Trial on Enbrel Biosimilar Delayed – How Long will Infliximab Biosimilars Dominate the US Anti-TNF Market?
Alexandra Annis, MS, Senior Immunology Analyst, GlobalData, assess what impact Sandoz’s delayed trial will have on the biosimilars market
Patient-Centric Clinical Trials ¦ Why Patient Advocacy is Vital
On International Clinical Trials Day, Robert Greene, HungerNdThirst Foundation, explains why patient advocacy is vital for clinical trial professionals
Read our magazine
Global Defence Technology is the essential reading material for decision-makers in the defence industry, bringing you the latest news and analysis in an exciting, interactive format.